Core Viewpoint - Credit Acceptance Corporation (CACC) reported a first-quarter 2025 earnings per share of $8.66, which was below the Zacks Consensus Estimate of $10.31, despite a year-over-year increase of 70.5% in earnings [1] Financial Performance - Adjusted net income for the quarter was $114.8 million or $9.35 per share, slightly down from $117.4 million or $9.28 per share in the same quarter last year [2] - Total GAAP revenues reached $571.1 million, reflecting a 12.4% year-over-year increase and surpassing the Zacks Consensus Estimate of $566.6 million [3] - Provision for credit losses decreased by 13% to $161.9 million, while operating expenses rose by 7.5% to $135.5 million [3] Asset and Equity Position - As of March 31, 2025, total assets were $9.26 billion, up from $8.85 billion at the end of December 2024, while total shareholders' equity decreased to $1.71 billion from $1.75 billion [4] Share Repurchase Activity - During the reported quarter, Credit Acceptance repurchased approximately 0.32 million shares [5] Market Outlook - The company faces challenges from rising expenses and weak asset quality, but is positioned for revenue growth due to increasing demand for consumer loans [6]

Core Insights - Prudential reported a revenue of $13.41 billion for the quarter ended March 2025, reflecting a 38.2% decrease year-over-year and a surprise of -7.71% compared to the Zacks Consensus Estimate of $14.53 billion [1] - The earnings per share (EPS) was $3.29, which is an increase from $3.12 in the same quarter last year, resulting in an EPS surprise of +2.49% against the consensus estimate of $3.21 [1] Financial Performance Metrics - Assets Under Management and Administration (PGIM) for institutional customers stood at $620.2 billion, below the average estimate of $632.98 billion [4] - Retail customer assets were reported at $240.6 billion, significantly lower than the estimated $374.12 billion [4] - Total assets under management for PGIM were $1,385.3 billion, compared to the average estimate of $1,401.42 billion [4] - Total revenues from U.S. businesses were $7.71 billion, a decline of 51.7% year-over-year, and below the average estimate of $8.50 billion [4] - International businesses generated total revenues of $4.74 billion, slightly above the estimated $4.60 billion, with a year-over-year change of +0.5% [4] - Adjusted operating income from policy charges and fee income was $1.11 billion, close to the average estimate of $1.12 billion [4] - Net investment income was reported at $4.52 billion, slightly above the average estimate of $4.47 billion [4] - Premiums totaled $6.45 billion, below the estimated $7.67 billion [4] - Corporate and other revenues reported a loss of $17 million, significantly lower than the average estimate of $70.97 million, representing a year-over-year change of -156.7% [4] - Individual life revenues from U.S. businesses were $1.52 billion, slightly below the estimated $1.57 billion, reflecting a -4.1% change year-over-year [4] - Group insurance revenues from U.S. businesses were $1.75 billion, exceeding the estimated $1.64 billion, with a year-over-year increase of +7% [4] Stock Performance - Prudential's shares have returned -6.9% over the past month, contrasting with the Zacks S&P 500 composite's -0.2% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - First Mid Bancshares (FMBH) reported revenue of $84.27 million for the quarter ended March 2025, reflecting a year-over-year increase of 5.4% [1] - The earnings per share (EPS) for the quarter was $0.96, up from $0.93 in the same quarter last year, with an EPS surprise of +2.13% compared to the consensus estimate of $0.94 [1] Financial Performance Metrics - The efficiency ratio was reported at 58.9%, better than the average estimate of 61.2% from three analysts [4] - The net interest margin stood at 3.6%, exceeding the average estimate of 3.4% from three analysts [4] - Average earning assets were $6.77 billion, slightly below the estimated $6.86 billion from two analysts [4] - Non-interest income was $24.86 million, lower than the average estimate of $26.94 million from three analysts [4] - Wealth management revenues matched the average estimate at $5.80 million [4] - Insurance commissions were reported at $9.93 million, below the average estimate of $10.18 million from two analysts [4] - Service charges totaled $2.90 million, compared to the average estimate of $3.04 million from two analysts [4] - Net interest income (FTE) was $60.16 million, surpassing the average estimate of $57.90 million from two analysts [4] - ATM/debit card revenue was $3.65 million, lower than the estimated $4.07 million from two analysts [4] - Other income was reported at $2.06 million, below the average estimate of $3 million from two analysts [4] - Net interest income was $59.41 million, exceeding the average estimate of $57.82 million from two analysts [4] - Mortgage banking revenues were $0.71 million, below the average estimate of $0.89 million from two analysts [4] Stock Performance - Shares of First Mid Bancshares have returned -2.1% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Tandem Diabetes Care, Inc. reported $234.42 million in revenue for Q1 2025, a year-over-year increase of 22.3% [1] - The EPS for the same period was -$0.67, compared to -$0.63 a year ago, indicating a decline [1] - The revenue exceeded the Zacks Consensus Estimate of $220.24 million by 6.44%, while the EPS fell short of the consensus estimate of -$0.60 by 11.67% [1] Financial Performance Metrics - The company’s stock has returned -10.5% over the past month, underperforming the Zacks S&P 500 composite, which changed by -0.2% [3] - Tandem Diabetes Care has a Zacks Rank 4 (Sell), suggesting potential underperformance in the near term [3] Pump Shipments and Sales - U.S. pump shipments totaled 17,000, slightly above the average estimate of 16,952 [4] - Total worldwide pump shipments were 28,000, below the average estimate of 29,200 [4] - Outside the U.S., pump shipments were 11,000, compared to the average estimate of 12,248 [4] Geographic Sales Performance - Geographic sales outside the U.S. reached $83.79 million, exceeding the average estimate of $74.74 million, representing a year-over-year change of +35.4% [4] - U.S. pump sales were $72.14 million, slightly above the average estimate of $71.94 million, with a year-over-year increase of +16.9% [4] - Sales of supplies and other products in the U.S. amounted to $78.49 million, surpassing the average estimate of $74.32 million, reflecting a year-over-year change of +13.5% [4] - Outside the U.S., pump sales were $29.95 million, below the average estimate of $31.46 million, with a year-over-year change of +17.1% [4] - Sales of supplies and other products outside the U.S. reached $53.84 million, exceeding the average estimate of $43.03 million, representing a year-over-year change of +48.1% [4] - Total geographic revenues in the U.S. were $150.63 million, above the average estimate of $146.17 million, with a year-over-year change of +16.1% [4] - Non-GAAP geographic revenues in the U.S. were $150.63 million, compared to the average estimate of $146.45 million [4] - Revenue from supplies and other products was $132.33 million, exceeding the average estimate of $118.22 million [4] - Pump revenue was $102.09 million, slightly below the average estimate of $102.82 million [4]

Financial Performance - FinWise Bancorp reported revenue of $22.09 million for the quarter ended March 2025, marking a year-over-year increase of 13.5% [1] - The earnings per share (EPS) for the same period was $0.23, compared to $0.25 a year ago, indicating a decline [1] - The reported revenue was a surprise of -2.21% compared to the Zacks Consensus Estimate of $22.59 million [1] - The EPS surprise was -8.00% against the consensus estimate of $0.25 [1] Key Metrics - The efficiency ratio was reported at 64.8%, slightly above the two-analyst average estimate of 64.3% [4] - The net interest margin was 8.3%, lower than the average estimate of 9.8% based on two analysts [4] - Total interest-earning assets amounted to $700.50 million, exceeding the average estimate of $656.54 million [4] - Non-performing loans were reported at $29.88 million, significantly lower than the average estimate of $46.24 million [4] - The net charge-offs to average loans ratio was 1.9%, better than the average estimate of 2.6% [4] - Total non-interest income was $7.81 million, surpassing the average estimate of $6.57 million [4] - Net interest income was reported at $14.28 million, below the average estimate of $15.98 million [4] Stock Performance - Shares of FinWise Bancorp have returned -9.4% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), suggesting potential outperformance against the broader market in the near term [3]

Core Insights - Albemarle reported $1.08 billion in revenue for Q1 2025, a year-over-year decline of 20.9% and below the Zacks Consensus Estimate of $1.17 billion, resulting in a surprise of -8.07% [1] - The company experienced an EPS of -$0.18, compared to $0.26 a year ago, with an EPS surprise of +70.97% against a consensus estimate of -$0.62 [1] Revenue Performance - Net Sales in Energy Storage were $524.57 million, down 34.5% year-over-year and below the average estimate of $588.57 million [4] - Net Sales for Ketjen were $231.30 million, a decrease of 5.1% year-over-year, compared to the estimated $243.93 million [4] - Net Sales in Specialties reached $321.01 million, showing a slight increase of 1.6% year-over-year, but below the average estimate of $329.98 million [4] EBITDA Analysis - Adjusted EBITDA for Energy Storage was $186.36 million, exceeding the average estimate of $132.93 million [4] - Adjusted EBITDA for Corporate was -$16.47 million, worse than the average estimate of -$9.39 million [4] - Adjusted EBITDA for Ketjen was $38.59 million, surpassing the average estimate of $27.55 million [4] - Adjusted EBITDA for Specialties was $58.67 million, slightly above the average estimate of $55.43 million [4] Stock Performance - Albemarle's shares have returned -17.2% over the past month, contrasting with the Zacks S&P 500 composite's -0.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Group 1 - Sixth Street (TSLX) reported revenue of $116.35 million for Q1 2025, a year-over-year decline of 1.2%, with EPS remaining unchanged at $0.58 compared to the previous year [1] - The reported revenue fell short of the Zacks Consensus Estimate of $118.42 million, resulting in a surprise of -1.75%, while the EPS exceeded the consensus estimate of $0.56 by 3.57% [1] - The stock has returned -6.9% over the past month, underperforming the Zacks S&P 500 composite, which saw a change of -0.2% [3] Group 2 - Total investment income from non-controlled non-affiliated investments was $113.92 million, slightly below the average estimate of $114.50 million from two analysts [4] - Investment income from controlled, affiliated investments was reported as $2.43 million, matching the average estimate, while total investment income from these investments was also slightly below the average estimate of $2.44 million [4]

Core Insights - Public Storage (PSA) reported revenue of $1.18 billion for Q1 2025, a 2.2% year-over-year increase, with an EPS of $4.12 compared to $2.60 a year ago, indicating strong financial performance [1] - The revenue exceeded the Zacks Consensus Estimate by 1.01%, while the EPS also surpassed expectations by 1.48% [1] Financial Performance Metrics - Square Foot Occupancy was reported at 91.5%, slightly above the three-analyst average estimate of 91% [4] - Rent per Occupied Square Foot was $22.58 million, marginally below the two-analyst average estimate of $22.61 million [4] - Revenue from self-storage facilities reached $1.10 billion, exceeding the $1.09 billion average estimate from five analysts, reflecting a year-over-year increase of 1.6% [4] - Revenue from ancillary operations was $80.19 million, surpassing the four-analyst average estimate of $78.36 million, with a year-over-year change of 12.7% [4] - Net Earnings Per Share (Diluted) was reported at $2.04, below the six-analyst average estimate of $2.41 [4] Stock Performance - Public Storage shares have returned -2% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]

Core Insights - Cognizant reported revenue of $5.12 billion for the quarter ended March 2025, reflecting a year-over-year increase of 7.5% and surpassing the Zacks Consensus Estimate by 0.95% [1] - The earnings per share (EPS) for the quarter was $1.23, up from $1.12 in the same quarter last year, exceeding the consensus EPS estimate of $1.19 by 3.36% [1] Financial Performance by Segment - Financial Services revenue was $1.46 billion, exceeding the average estimate of $1.43 billion, with a year-over-year increase of 5.6% [4] - Communications, Media and Technology revenue was $804 million, below the estimated $833.33 million, representing a year-over-year decline of 2.7% [4] - Products and Resources revenue reached $1.28 billion, slightly above the estimated $1.27 billion, with a year-over-year increase of 12.8% [4] - Health Sciences revenue was $1.57 billion, surpassing the average estimate of $1.55 billion, reflecting a year-over-year growth of 11% [4] Stock Performance - Cognizant's shares have returned -4.1% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Humana Inc. (HUM) reported first-quarter 2025 adjusted earnings of $11.58 per share, which outpaced the Zacks Consensus Estimate by 16%. The bottom line soared 60.2% year over year. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Adjusted revenues improved 9.5% year over year to $32.1 billion. However, the top line missed the consensus mark by 0.3%. The quarterly results benefited on the back of strong premiums resulting from an expanding customer base in stand-alone prescription drug ...